ZBH - Company ID 0001136869
The table below shows ZIMMER BIOMET HOLDINGS, INC.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $2.09B | $2.00B | $2.08B | $1.91B | $1.82B | $1.94B |
| Cost of revenue | $576.20M | $559.30M | $592.20M | $549.80M | $538.60M | $553.60M |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
ZIMMER BIOMET HOLDINGS, INC. reported annual revenue of $8.23B for fiscal year 2025. That is up 7.2% from $7.68B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $7.67B (FY 2016) to $8.23B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $849.90M |
| $811.40M |
| $814.80M |
| $758.80M |
| $709.70M |
| $737.10M |
| Operating income | $373.20M | $351.30M | $300.00M | $292.30M | $279.50M | $351.30M |
| Income tax | $63.00M | $48.00M | $71.20M | $46.50M | -$18.90M | $59.10M |
| Net income | $238.10M | $230.90M | $152.80M | $182.00M | $249.10M | $242.80M |
| EPS (diluted) | $1.22 | $1.16 | $0.77 | $0.91 | $1.23 | $1.18 |